Yarong Liu is the founder of GRIT Biotechnology. GRIT Biotechnology has raised $60M in total funding. Latest round: Series B. Based in Shanghai, China.
Yarong Liu is the Chief Executive Officer of Grit Therapeutics, also known as Grit Biotechnology. He has led the cell therapy company since January 2020, focusing on developing tumor infiltrating lymphocyte (TIL) products. Under his leadership, Grit Bio has dosed its first patient in the Phase 1 trial of GT101, the first TIL product to receive IND approval in China.
Full founder directory · Investor directory · Company funding database · Fundraising library